Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 2 SUPPL., 1997, Pages 381-393

  Wazer, David E ^a,b   Kramer, Bradley ^a   Schmid, Christopher ^a   Ruthazer, Robin ^a   Ulin, Kenneth ^a   Schmidt Ullrich, Rupert ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast carcinoma; Breast conservation; Interstitial implant boost

Indexed keywords

COBALT 60; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; ISOTOPE; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; DRUG IMPLANT; ESTHETICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION INJURY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; ESTHETICS; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0030817157     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00325-8     Document Type: Article

References (42)

1. Bedwineck, J. Breast conserving surgery and irradiation: The importance of demarcating the excision cavity with surgical clips. Int. J. Radiat. Oncol. Biol. Phys. 26:675-679; 1993.
2. Chu, A. M.; Cope, O.; Russo, R.; Lew, R. Patterns of locoregional recurrence and results in Stages I and II breast cancer treated by irradiation following limited surgery: An update. Am. J. Clin. Oncol. 7:221-229; 1984.
3. Clarke, D. H.; Martinez, A. A. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: A review article for surgeons, pathologists, and radiation and medical oncologists. J. Clin. Oncol. 10:474-483; 1992.
4. Denham, J. W.; Carter, M. L. Conservative treatment of breast cancer - Where should the booster dose go? Int. J. Radiat. Oncol. Biol. Phys. 14:399; 1988.
5. Deore, S. M; Sarin, R.; Dinshaw, K.; Shrivastava, S. K. Influence of dose rate and dose-per-fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: Analysis of 289 cases. Int. J. Radiat. Oncol. Biol. Phys. 26:601-606; 1993.
6. Fisher, B.; Redmond, C.; Poisson, R.; Margolese, R.; Wolmark, N.; Wickerham, L.; Fisher, E.; Deutsch, M.; Caplan, R.; Pilch, Y.; Glass, A.; Shibata, H.; Lerner, H.; Terz, H.; Sidorivich, L. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Eng. J. Med. 320:822-828; 1989.
7. Fourquet, A.; Campana, F.; Mosseri, V.; Cetingoz, R.; Luciani, S.; Labib, A.; Asselain, B.; Vilcoq, J. R. Iridium-192 vs. cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: Final results of a randomized trial. Radiother. Oncol. 34:114-120; 1995.
8. Fowble, B.; Solin, L. J.; Schultz, D. J.; Rubinstein, J.; Goodman, R. Breast recurrence following conservative surgery and irradiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implication for treatment. Int. J. Radiat. Oncol. Biol. Phys. 19:833-842; 1990.
9. Gage, I.; Nixon, A. J.; Schnitt, S. J.; Recht, A.; Gelman, R.; Silver, B.; Connolly, J. L.; Harris, J. R. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 32 (Suppl. 1):210; 1995.
10. Gwin, J. L.; Eisenberg, B. L.; Hoffman, J. P.; Ottery, F. D.; Boraas, M.; Solin, L. J. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann. Surg. 218:729-734; 1993.
11. Harris, J. R.; Beadle, G. F.; Hellman, S. Clinical studies on the use of radiation therapy as primary treatment of early breast cancer. Cancer 53:705-711; 1984.
12. Holland, R.; Veling, S. H.; Matrunac, M.; Hendricks, H. C. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials on breast conserving therapy. Cancer 56:979-991; 1985.
13. Krishnan, L.; Krishnan, E. C.; Mansfield, C. M.; Reddy, E. K.; Thomas, J. H.; Jewell, W. R. Treatment options in early breast cancer. Radiographics 9:1067-1079; 1989.
14. Kuske, R.; Bolton, J. S. A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma. Radiation Therapy Oncology Group trial (RTOG #1055) (draft). Philadelphia, PA; 1995.
15. Machtay, M.; Lanciano, R.; Hoffman, J.; Hanks, G. E. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 30:43-48; 1994.
16. Mansfield, C. M.; Komarnicky, L. T.; Schwartz, G.; Rosenberg, A. L.; Krishnan, L.; Jewell, W. R.; Rosato, F. E.; Moses, F. L.; Barbot, D.; Cohn, H. E.; Gillum, D. R.; Taylor, J.; Bennammar, A.; Swenson, L. Perioperative implantation of Iridium-192 as the boost technique for stage I and II breast cancer: Results of a 10-year study of 655 patients. Radiology 192:33-36; 1994.
17. Mansfield, C. M.; Komarnicky, L. T.; Schwartz, G.; Rosenberg, A. L.; Krishnan, L.; Jewell, J.; Rosato, F. E.; Moses, M. L.; Haghbin, M.; Taylor, J. Ten-year results in 1070 patients with stage I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 75:2328-2336; 1995.
18. Mayr, N. A.; Robinson, R. A.; Wen, B.; Ross, C.; Hass, A.; Stoffel, T.; Fisher, D.; Vanmetre, J.; Hussey, D. Morphometric studies in early stage breast cancer with an intraductal component using computerized image analysis. Radiat. Oncol. Invest. 1:153-166; 1993.
19. McCrae, D.; Rodgers, J.; Dritschilo, A. Dose-volume and complication in interstitial implants for breast carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 13:515-529; 1987.
20. Olivotto, I.; Rose, M.; Osteen, R.; Love, S.; Cady, B.; Silver, B.; Recht, A.; Harris, J. R. Late cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes of cosmetic failure. Int. J. Radiat. Oncol. Biol. Phys. 17:747-753; 1989.
21. Perez, C. A.; Taylor, M. E.; Halverson, K.; Garcia, D.; Kuske, R. R.; Lockett, M. A. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: A nonrandomized comparison. Int. J. Radiat. Oncol. Biol. Phys. 34:995-1007; 1996.
22. Ray, G. R.; Fish, V. J. Biopsy and definitive radiation therapy in Stage I and II adenocarcinoma of the female breast: Analysis of cosmesis and the role of electron beam supplementation. Int. J. Radiat. Oncol. Biol. Phys. 9:813-818; 1983.
23. Recht, A.; Silver, B.; Schnitt, S.; Connolly, J.; Hellman, S.; Harris, J. R. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency, and salvage. Int. J. Radiat. Oncol. Biol. Phys. 11:1271-1276; 1985.
24. Recht, A.; Triedman, S.; Harris, J. R. The "boost" in the treatment of early stage breast cancer: Electrons vs. interstitial implants. In: Vaeth, J. M.; Meyer, J. L., eds. The role of high energy electrons in the treatment of cancer. Frontiers of radiation oncology, vol. 25. Basel, Switzerland: Karger; 1991:169-179.
25. Regine, W. F.; Ayyanger, K. M.; Komarnicky, L. T.; Bhandare, N.; Mansfield, C. M. Computer-CT planning of the electron boost in definitive breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 20:121-125; 1991.
26. Saw, C. B.; Suntharalingam, N. Quantitative assessment of interstitial implants. Int. J. Radiat. Oncol. Biol. Phys. 20:135-139; 1991.
27. Saw, C. B.; Suntharalingam, N.; Wu, A. Concept of dose nonuniformity in interstitial brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 26:519-527; 1993.
28. Schmidt-Ullrich, R.; Wazer, D. E.; DiPetrillo, T.; Marchant, D.; Smith, T. J.; Safaii, H.; Schmid, C.; Homer, M. J. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: A case for aggressive therapy to the tumor-bearing quadrant. Int. J. Radiat. Oncol. Biol. Phys. 27:545-552; 1993.
29. Schmidt-Ullrich, R.; Wazer, D. E.; Tercilla, O.; Safaii. H.; Marchant, D. J.; Smith, T. J.; Homer, M.; Robert, N. J. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 17:733-738; 1989.
30. Schnitt, S. J.; Abner, A.; Gelman, R.; Connolly, J. L.; Recht, A.; Duda, R. B.; Eberlein, T.; Mayzel, K.; Silver, B.; Harris, J. R. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast conserving surgery and radiation therapy. Cancer 74:1746-1751; 1994.
31. Schnitt, S.; Connolly, J.; Harris, J. R.; Hellman, S.; Cohen, R. B. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057; 1984.
32. Sedlmayer, F.; Rahim, H. B. K.; Kogelnik, H.; Menzel, C.; Merz, F.; Deustchmann, H.; Kranzinger, M. Quality assurance in breast cancer brachytherapy: Geographic miss in the interstitial boost treatment of the tumor bed. Int. J. Radiat. Oncol. Biol. Phys. 34:1133-1139; 1996.
33. Solin, L. J.; Danoff, B.; Schwartz, G.; Galvin, J. M.; Goodman, R. A practical technique for the localization of the tumor volume in definitive irradiation of the breast. Int. J. Radiat. Oncol. Biol. Phys. 11:1215-1220; 1985.
34. Touboul, E.; Belkacemi, Y.; Lefranc, J.-P.; Uzan, S.; Ozahin, M.; Korbas, D.; Buffat, L.; Balosso, J.; Pene, F.; Blondon, J.; Schlienger, M.; Laugier, A. Early breast cancer: Influence of type of boost (electrons vs. iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother. Oncol. 34:105-113; 1995.
35. van Limbergen, E.; van den Bogaert, W.; van der Schueren, E.; Rijinders, A. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother. Oncol. 8:1-9; 1987.
36. Vicini, F.; White, J.; Gustafson, G.; Matter, R.; Clarke, D.; Edmundsen, G.; Martinez, A. The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants. Int. J. Radiat. Oncol. Biol. Phys. 27:561-566; 1993.
37. Wazer, D. E.; DiPetrillo, T.; Schmidt-Ullrich, R.; Weld, L.; Smith, T. J.; Marchant, D. J.; Robert, N. J. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J. Clin. Oncol. 10:356-363; 1992.
38. Wazer, D. E.; Erban, J.; Robert, N. J.; Smith, T. J.; Marchant, D. J.; Schmid, C.; DiPetrillo, T.; Schmidt-Ullrich, R. Breast Conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 74:878-883; 1994.
39. Wazer, D. E.; Sinesi, M.; Schmidt-Ullrich, R.; Smith, T. J.; Safaii, H.; Marchant, D. J.; Homer, M.; Robert, N. Importance of surgical and pathologic determinants of tumor margin status for breast conservation therapy. Breast Dis. 4:285-292; 1991.
40. Wu, A.; Ulin, K.; Sternick, E. S. A dose homogeneity index for evaluating iridium-192 interstitial breast implants. Med. Phys. 15:104-107;1988.
41. Zwicker, R. D.; Schmidt-Ullrich, R. Dose uniformity in a planar interstitial implant system. Int. J. Radiat. Oncol. Biol. Phys. 31:149-155; 1995.
42. Zwicker, R. D.; Schmidt-Ullrich, R.; Schiller, B. Planning of Ir-192 seed implants for boost irradiation to the breast. Int. J. Radiat. Oncol. Biol. Phys. 11:2163-2170; 1985.